The US has a federal policy agenda but no enforceable ink limits, the EU has limits but no proven allergy impact, and Australia remains unregulated with all tested inks failing EU rules. Studios need batch-level data now.
Executive Summary The global regulatory framework for tattoo inks is fracturing along national lines, creating a compliance minefield for studios and manufacturers. In 2026, the United States, European Union, and Australia operate under fundamentally different assumptions about what constitutes a safe pigment. The US, despite the Modernization of Cosmetics Regulation Act (MoCRA), still lacks enforceable composition limits for intradermal exposure [1]. The EU's REACH restriction, in force since 2022, pairs chemical limits with labeling but has yet to demonstrate a measurable impact on tattoo-ink allergies [4]. Australia remains a regulatory vacuum, with a 2026 study finding that 100% of tested inks would be prohibited under EU rules [2]. For studio owners, this divergence means the ink you purchase legally in one jurisdiction can be a liability in another. The engineering-first approach demands you stop relying on country-of-sale compliance and start demanding batch-level data.
Read the full engineering article on Poli International →
Full data, references, and the complete technical breakdown, free, no signup.
First published on poliinternational.com. This is a summary of the original engineering article.
Top comments (0)